Kezar Life Sciences
Biotechnology
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

$49.9M

Market Cap • 12/26/2024

2015

(9 years)
Founded

2018

(6 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

South San Francisco

Headquarters • California